Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

TARSH Inhibitors

TARSH inhibitors represent a class of chemical compounds that are known for their ability to interfere with the activity of the TARSH (Tandem Anion Recognition and Suppression Hub) enzyme system. The TARSH system is integral to a variety of biochemical pathways, particularly those involved in anion recognition and coordination. TARSH enzymes play a crucial role in the regulation of charged particle movement, specifically by interacting with various anions such as phosphates, nitrates, and sulfates. Inhibitors of this system function by blocking the enzyme's active site or by inducing conformational changes that diminish its efficiency in binding and recognizing these anions. This type of inhibition leads to a cascade of effects on cellular homeostasis and biochemical balances, as anion recognition is fundamental to numerous biochemical and molecular interactions in the cell.

The chemical structures of TARSH inhibitors are diverse, often containing functional groups that interact with specific regions of the TARSH enzymes. Many TARSH inhibitors possess polar groups or charged moieties that enable them to form ionic bonds or hydrogen bonds with key residues within the enzyme's active site. Some inhibitors operate through allosteric mechanisms, binding to sites outside the active site to induce a change in the enzyme's structure and reduce its activity indirectly. Research into TARSH inhibitors also explores the role of hydrophobic interactions and π-stacking with aromatic amino acid residues in stabilizing the inhibitor-enzyme complex. This complex molecular interaction plays a key role in the fine-tuned modulation of the TARSH enzyme system and the subsequent downstream effects on biochemical processes reliant on anion dynamics. The diversity of these inhibitors underscores the complexity and versatility of their interaction with the TARSH system.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor that alters chromatin structure, potentially reducing TARSH expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound incorporates into DNA and RNA, leading to hypomethylation of DNA which may downregulate TARSH expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA, inhibiting RNA polymerase and possibly decreasing TARSH transcription.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

Alpha-amanitin inhibits RNA polymerase II, which could result in decreased TARSH mRNA synthesis.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide blocks translational elongation, potentially reducing TARSH protein levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, a kinase involved in protein synthesis, which could indirectly lower TARSH levels.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine raises endosomal pH, which may affect cellular signaling and TARSH protein expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A binds DNA and prevents binding of transcription factors, possibly cutting down TARSH gene expression.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

MG-132 is a proteasome inhibitor that could lead to reduced degradation of transcriptional repressors of TARSH.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium Butyrate, a histone deacetylase inhibitor, can change gene expression patterns, potentially affecting TARSH.